Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Japanese approval for new formulation of Fosrenol

Feb. 3, 2012

Evotec and Harvard University form new alliance

Jan. 17, 2012

Trillium set to begin phase I TTI-1612 trial in Canada

Dec. 19, 2011

FDA approves new oxybutynin gel product

Dec. 12, 2011

ChemoCentryx begins new study of CCX-140 in diabetic nephropathy

Dec. 9, 2011

Primary endpoint met in Toviaz trial

Dec. 9, 2011

Spectrum Pharmaceuticals files IND with FDA for phosphate-binding agent

Dec. 7, 2011

New triterpenoid derivatives prepared by Concert Pharmaceuticals

Dec. 7, 2011

Novel mineralocorticoid receptor antagonists prepared by Pfizer

Dec. 5, 2011

Novartis discloses final results from EXIST-2 trial

Nov. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...